Compound Profile: Xmalon
Xmalon 25 mg is exemestane, a steroidal aromatase inhibitor manufactured by Celon Labs for advanced laboratory research applications. This pharmaceutical-grade compound irreversibly binds to the aromatase enzyme (CYP19A1), providing researchers with a potent tool for investigating estrogen biosynthesis pathways in cellular and molecular studies. Unlike reversible inhibitors, exemestane forms permanent covalent bonds with the enzyme active site, making it particularly valuable for research into hormonal regulation mechanisms.
As part of our comprehensive selection at Stroid UK Shop, Xmalon represents the highest standard in research chemicals for endocrinology studies. Each 25 mg tablet delivers consistent potency for reproducible experimental results, essential for peer-reviewed research protocols. The compound’s steroidal structure, derived from androstenedione, allows researchers to examine both its primary aromatase inhibition properties and secondary androgenic effects in comparative studies.
Laboratory Applications
Research scientists utilise exemestane in numerous investigational contexts, particularly in studies examining estrogen-dependent cellular processes and hormonal feedback mechanisms. The compound’s irreversible inhibition profile makes it invaluable for time-course studies investigating recovery of aromatase activity following treatment withdrawal. Cell culture experiments benefit from exemestane’s ability to create estrogen-depleted environments, enabling researchers to isolate and study estrogen-independent cellular pathways.
Comparative studies between exemestane and non-steroidal aromatase inhibitors provide insights into structure-activity relationships within this therapeutic class. Researchers working with hormone-responsive cell lines frequently incorporate Xmalon into their protocols to investigate the downstream effects of estrogen depletion on gene expression, protein synthesis, and cellular metabolism. The compound’s oral bioavailability data from clinical literature supports its use in pharmacokinetic modelling studies. Our aromatase inhibitors collection complements exemestane research with additional compounds for comprehensive studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Exemestane |
| CAS Registry Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Dosage Form | 25 mg tablets |
| Manufacturer | Celon Labs |
| Storage Conditions | Room temperature, dry environment |
| Mechanism | Irreversible aromatase inhibitor |
Research facilities requiring additional compounds for comprehensive hormonal studies can explore our SARMs collection and peptides range for complementary research applications. Quality control documentation accompanies each shipment to ensure research integrity.
Research Compliance
Xmalon 25 mg exemestane is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical use, or any therapeutic applications. This product is restricted to qualified research institutions and licensed laboratories conducting legitimate scientific investigations. Researchers must ensure compliance with all applicable regulations governing controlled substance research in their jurisdiction before procurement.
